Control Bionics Limited (ASX:CBL)
Australia flag Australia · Delayed Price · Currency is AUD
0.0590
-0.0010 (-1.67%)
At close: Feb 5, 2026

Control Bionics Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
-6.11-5.91-5.63-6.1-3.55
Depreciation & Amortization
0.990.840.480.510.2
Loss (Gain) From Sale of Assets
0.01----
Loss (Gain) on Equity Investments
0.06----
Stock-Based Compensation
0.120.140.040.050.09
Provision & Write-off of Bad Debts
0.240.510.630.08-
Other Operating Activities
0.01-0.020.06-0.41-0.3
Change in Accounts Receivable
-0.07-0.76-0.24-0.42-0.8
Change in Inventory
-0.01-0.050.12-0.65-0.09
Change in Accounts Payable
0.440.370.32-0.010.44
Change in Other Net Operating Assets
0.04-0.02-0.310.060.03
Operating Cash Flow
-4.27-4.91-4.54-6.89-3.99
Capital Expenditures
-0.3-0.4-0.42-0.15-0.05
Sale (Purchase) of Intangibles
-0.14-0.07-0.04--0.01
Investment in Securities
-0.3----
Investing Cash Flow
-0.74-0.47-0.46-0.15-0.05
Short-Term Debt Issued
0.230.65-0.24-
Total Debt Issued
0.230.65-0.24-
Short-Term Debt Repaid
-0.65-0.13-0.05-0.19-
Long-Term Debt Repaid
-0.16-0.05-0.11-0.09-0.05
Total Debt Repaid
-0.82-0.18-0.16-0.29-0.05
Net Debt Issued (Repaid)
-0.590.47-0.16-0.05-0.05
Issuance of Common Stock
5.415.090.860.0115.68
Other Financing Activities
-0.19-0.14--0.06-0.72
Financing Cash Flow
4.635.430.71-0.0914.92
Foreign Exchange Rate Adjustments
000.0100.02
Net Cash Flow
-0.390.05-4.28-7.1210.9
Free Cash Flow
-4.57-5.31-4.96-7.03-4.04
Free Cash Flow Margin
-74.40%-99.24%-87.84%-156.26%-98.78%
Free Cash Flow Per Share
-0.02-0.03-0.06-0.08-0.06
Cash Interest Paid
0.050.060.020.040.03
Levered Free Cash Flow
-2.45-2.59-2.56-5.37-1.83
Unlevered Free Cash Flow
-2.38-2.56-2.54-5.37-1.78
Change in Working Capital
0.41-0.46-0.11-1.02-0.42
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.